A Prospective Study of Intraperitoneal and Intravenous Nab-paclitaxel Plus Camrelizumab and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells
Latest Information Update: 27 Jun 2022
At a glance
- Drugs Bovine serum albumin (Primary) ; Camrelizumab (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Paclitaxel (Primary) ; Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
Most Recent Events
- 15 Jun 2022 New trial record